US Bancorp’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

US Bancorp’s Portfolio SCR Stock Details SCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-196	Closed	-$2K	–	3651
2013 Q4	$2K	Buy	+196	New	+$1.86K	﹤0.01%	3330

US Bancorp's SCR Position: Q1 2014 in Review

US Bancorp sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 196 shares — an estimated $2K sold.

US Bancorp first reported a position in SCR in Q4 2013 and held it in 1 quarter. The position peaked at $2K in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

US Bancorp reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
US Bancorp sold 196 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $2K.
US Bancorp first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q4 2013 and held it in 1 quarter.
US Bancorp's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $2K in Q4 2013.
0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on US Bancorp's 13F filing for Q1 2014, filed 14 May 2014.